Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Conte

Showing results (41-50 of 200) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|June 1, 1994
Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patientsI Brunetti, A Falcone, M Bertuccelli, et al.
Journal for Immunotherapy of Cancer|August 7, 2019
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challengesA Pavan, I Attili, G Pasello, et al.
Tumori|January 16, 1998
A dose-finding study of ifosfamide by three-day continuous infusion in pretreated, advanced breast cancer patientsA Michelotti, B Salvadori, S Donati, et al.
Cancer|July 15, 1993
Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II studyA Falcone, C Cianci, S Ricci, et al.
Oncology|November 1, 1993
Analysis of time to response to chemotherapy in 316 metastatic breast cancer patientsP Pronzato, G Bertelli, G Gardin, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2014
A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancerS Chan, M Campone, A Santoro, et al.
Oncology|January 1, 1986
Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymeraseA Alama, P F Conte, E Di Marco, et al.
Oncology|January 1, 1986
Survival of patients with relapsing breast cancer: analysis of 302 patientsR Lionetto, P Pronzato, G F Bertelli, et al.
ESMO Open|March 11, 2022
Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trialsV Guarneri, G Griguolo, F Miglietta, et al.
Basic and Applied Histochemistry|January 1, 1986
Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapyP F Conte, A Alama, E Di Marco, et al.
Pageof 20

Showing results (41-50 of 200) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|June 1, 1994
Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patientsI Brunetti, A Falcone, M Bertuccelli, et al.
Journal for Immunotherapy of Cancer|August 7, 2019
Immunotherapy in small-cell lung cancer: from molecular promises to clinical challengesA Pavan, I Attili, G Pasello, et al.
Tumori|January 16, 1998
A dose-finding study of ifosfamide by three-day continuous infusion in pretreated, advanced breast cancer patientsA Michelotti, B Salvadori, S Donati, et al.
Cancer|July 15, 1993
Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II studyA Falcone, C Cianci, S Ricci, et al.
Oncology|November 1, 1993
Analysis of time to response to chemotherapy in 316 metastatic breast cancer patientsP Pronzato, G Bertelli, G Gardin, et al.
Cancer Chemotherapy and Pharmacology|March 15, 2014
A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancerS Chan, M Campone, A Santoro, et al.
Oncology|January 1, 1986
Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymeraseA Alama, P F Conte, E Di Marco, et al.
Oncology|January 1, 1986
Survival of patients with relapsing breast cancer: analysis of 302 patientsR Lionetto, P Pronzato, G F Bertelli, et al.
ESMO Open|March 11, 2022
Survival after neoadjuvant therapy with trastuzumab-lapatinib and chemotherapy in patients with HER2-positive early breast cancer: a meta-analysis of randomized trialsV Guarneri, G Griguolo, F Miglietta, et al.
Basic and Applied Histochemistry|January 1, 1986
Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapyP F Conte, A Alama, E Di Marco, et al.
Pageof 20